Health Condition 1: N17-N19- Acute kidney failure and chronic kidney disease
Conditions
Interventions
Control Intervention1: NIL: NIL
Sponsors
KLEs DrPRABHAKAR KORE HOSPITAL AND MRC BELAGAVI
Eligibility
Inclusion criteria
Inclusion criteria: The study included patients over the age of 18 who had a confirmed diagnosis of Chronic Kidney Disease (CKD),able to read and understand the language of the assessment tools used, and willing to provide informed consent and complete all study procedures.
Exclusion criteria
Exclusion criteria: Patients were excluded if they had incomplete demographic or laboratory data, had conditions other than Chronic Kidney Disease (CKD), were unwilling to provide necessary information, were experiencing an acute psychiatric crisis requiring immediate intervention, had a terminal illness with limited life expectancy, were unable to participate due to severe physical limitations, or were over the age of 80.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the prevalence of anxiety and depression in chronic kidney disease (CKD) patients using the appropriate scales.Timepoint: 6 MONTHS | — |
Secondary
| Measure | Time frame |
|---|---|
| TO ASSESS THE CO-RELATION OF ANXIETY AND DEPRESSION WITH QOL IN CKD PATIENTS.Timepoint: 6 MONTHS;TO ASSESS THE EFFECTS OF VARIOUS SOCIO-DEMOGRAPHIC AND DISEASE FACTORS OF ANXIETY AND DEPRESSION ON QOL IN CKD PATIENTS.Timepoint: 6 MONTHS | — |
Countries
India
Contacts
Public ContactDr. Geetanjali Salimath
KLE COLLEGE OF PHARMACY BELAGAVI
Outcome results
None listed